Stock STTK SHATTUCK LABS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shattuck Labs, Inc.

Equities

STTK

US82024L1035

Biotechnology & Medical Research

Real-time Estimate Cboe BZX
Other stock markets
 02:13:03 2024-04-26 pm EDT 		5-day change 1st Jan Change
10.41 USD +6.44% Intraday chart for Shattuck Labs, Inc. +8.66% +46.00%
Mar. 04 Shattuck Labs, Inc. Announces Board Appointments CI
Mar. 01 Sector Update: Health Care Stocks Rising Late Afternoon MT

Business Summary

Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.

Number of employees: 75

Sales per Business

USD in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
1 100.0 % 2 100.0 % +154.14%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
1 100.0 % 2 100.0 % +154.14%

Managers

Managers TitleAgeSince
Taylor Schreiber FOU
 Founder 44 15-12-31
Andrew Neill DFI
 Director of Finance/CFO 38 19-06-30
Stephen Stout CMP
 Compliance Officer 49 20-12-31
Lini Pandite CTO
 Chief Tech/Sci/R&D Officer 65 17-06-30
Amy Franke CTO
 Chief Tech/Sci/R&D Officer - 22-09-30
Abhinav Shukla CTO
 Chief Tech/Sci/R&D Officer 51 21-05-31
Conor Richardson IRC
 Investor Relations Contact - 18-12-31
Suresh de Silva PRN
 Corporate Officer/Principal 45 18-11-30
George Fromm
45 -
Thomas M. Lampkin LAW
 General Counsel - 18-03-31

Members of the board

Members of the board TitleAgeSince
Neil Gibson BRD
 Director/Board Member 67 16-10-31
George Golumbeski CHM
 Chairman 67 17-12-31
Michael Lee BRD
 Director/Board Member 45 20-05-31
Helen Boudreau BRD
 Director/Board Member 58 20-07-21
Taylor Schreiber FOU
 Founder 44 15-12-31
Carrie Brownstein BRD
 Director/Board Member 54 21-10-21
Tyler Brous BRD
 Director/Board Member 41 16-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 47,474,783 41,256,071 ( 86.90 %) 0 86.90 %

Shareholders

NameEquities%Valuation
Fidelity Management & Research Co. LLC
14.89 %
7,071,174 14.89 % 63 M $
Redmile Group LLC
11.84 %
5,619,914 11.84 % 50 M $
Redmile Group LLC
11.83 %
5,615,489 11.83 % 50 M $
Josiah Hornblower
6.272 %
2,977,627 6.272 % 27 M $
Prosight Management LP
5.862 %
2,782,797 5.862 % 25 M $
Taylor Schreiber
5.809 %
2,757,686 5.809 % 25 M $
Adage Capital Management LP
5.430 %
2,577,705 5.430 % 23 M $
Adage Capital Partners GP LLC
3.692 %
1,752,705 3.692 % 16 M $
Franklin Advisers, Inc.
3.446 %
1,635,821 3.446 % 15 M $
The Clark Estates, Inc.
3.108 %
1,475,648 3.108 % 13 M $

Company contact information

Shattuck Labs, Inc.

500 West 5th Street Suite 1200

78701, Austin

+

http://www.shattucklabs.com
address Shattuck Labs, Inc.(STTK)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
9.78 USD
Average target price
15.75 USD
Spread / Average Target
+61.04%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SHATTUCK LABS, INC. Stock Shattuck Labs, Inc.
+46.00% 465M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.87% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+8.52% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.97% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-24.50% 18.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.89% 12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.80% 11.7B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+7.11% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. STTK Stock
  4. Company Shattuck Labs, Inc.